From January 1, 2023 to May 23, 2023, the company has repurchased 202,445 shares, representing 0.6% for KRW 2,286 million. With this, the company has completed the repurchase of 1,840,483 shares, representing 5.22% for KRW 29,899.64 million under the buyback announced on March 24, 2022.
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
7,620 KRW | -0.65% | +16.16% | -15.05% |
2023 | Access Bio, Inc. acquired an unknown minority stake in CuraPatient Inc. | CI |
2023 | Tranche Update on Access Bio, Inc.'s Equity Buyback Plan announced on March 24, 2022. | CI |
1st Jan change | Capi. | |
---|---|---|
-15.05% | 191M | |
-4.42% | 12.33B | |
-4.35% | 8.14B | |
+30.81% | 5.62B | |
-7.42% | 4.24B | |
-54.27% | 3.06B | |
+14.44% | 2.76B | |
-2.57% | 2.41B | |
+28.53% | 2.23B | |
-4.67% | 1.87B |
- Stock Market
- Equities
- A950130 Stock
- News Access Bio, Inc.
- Tranche Update on Access Bio, Inc.'s Equity Buyback Plan announced on March 24, 2022.